Select Page

2024

Practical Considerations of Laser Enucleation Programs

Practical Considerations of Laser Enucleation Programs

Posted by | Aug 2024

Ilya Sobol, MD, provides an in-depth analysis of the practical considerations involved in implementing and managing laser enucleation programs for benign prostatic hyperplasia (BPH). His discussion focuses on the technical aspects, patient selection, and logistical requirements essential for the successful execution of these programs.

Dr. Sobol outlines the advantages of laser enucleation techniques, such as holmium laser enucleation of the prostate (HoLEP). Dr. Sobol also discusses the technical expertise required for performing laser enucleation. He highlights the necessity for specialized training and experience to master the technique. Logistical considerations are also addressed, including the need for appropriate facilities and equipment.

Read More
Overview of Current Surgical BPH

Overview of Current Surgical BPH

Posted by | Aug 2024

Amy Krambeck, MD, provides a comprehensive overview of current surgical options for treating benign prostatic hyperplasia (BPH), focusing on their efficacy, safety, and practical application. Her analysis emphasizes the evolution of surgical techniques and the criteria for selecting the most appropriate intervention for each patient.

Dr. Krambeck begins by discussing transurethral resection of the prostate (TURP), noting its potential complications, such as bleeding, infection, and the risk of TUR syndrome, which necessitates careful patient selection and postoperative monitoring. She then explores newer surgical techniques as alternatives to TURP, among these, laser therapies such as holmium laser enucleation of the prostate (HoLEP) and photoselective vaporization of the prostate (PVP). Dr. Krambeck also addresses minimally invasive surgical options like prostatic urethral lift (PUL) and water vapor thermal therapy.

The discussion includes a review of the practical considerations for each surgical option, including patient factors such as prostate size, comorbidities, and symptom severity. Complications and postoperative care are also discussed.

Read More
iTIND: How I Do It

iTIND: How I Do It

Posted by | Aug 2024

Amin S. Herati, MD, provides an in-depth analysis of the implantation of the Temporary Implantable Nitinol Device (iTIND) for the treatment of benign prostatic hyperplasia (BPH). His discussion emphasizes the procedural details, benefits, and practical considerations of using iTIND, a minimally invasive therapy designed to relieve urinary symptoms associated with BPH.

Dr. Herati describes the indications for iTIND, highlighting its suitability for patients with moderate to severe BPH who are seeking alternatives to medication or more invasive surgical procedures. The procedural technique is meticulously detailed; Dr. Herati emphasizes the technical aspects critical to the procedure’s success, such as the precise placement of the device and careful monitoring during the implantation and removal processes.

The benefits of iTIND are highlighted, including its minimally invasive nature, rapid symptom relief, and preservation of sexual function. Additionally, the low incidence of complications, such as temporary dysuria and hematuria, is discussed. Challenges and limitations of iTIND are also addressed.

Read More
Overview of Current MIST: Practical Considerations

Overview of Current MIST: Practical Considerations

Posted by | Aug 2024

Kevin C. Zorn, MD, FRCSC, FACS, provides an authoritative overview of current minimally invasive surgical techniques (MIST) for the treatment of benign prostatic hyperplasia (BPH). His analysis emphasizes the advancements in MIST and their role in providing effective and patient-friendly alternatives to traditional surgical approaches.

Dr. Zorn highlights the primary MIST options currently available, including transurethral resection of the prostate (TURP), photoselective vaporization of the prostate (PVP), holmium laser enucleation of the prostate (HoLEP), and newer techniques such as water vapor thermal therapy and prostatic urethral lift (PUL). The procedural nuances of each MIST option are discussed in detail.

Dr. Zorn examines the outcomes and benefits of MIST as well as the challenges and limitations of the procedures. Future directions in MIST are considered, with Dr. Zorn highlighting ongoing research and innovation to further refine these techniques and expand their applicability. The integration of advanced imaging technologies and the development of novel therapeutic devices hold promise for enhancing the precision and effectiveness of MIST.

Read More
Prostate Urethral Lift. How I Do It.

Prostate Urethral Lift. How I Do It.

Posted by | Aug 2024

Amin S. Herati, MD provides an overview of the prostate urethral lift (PUL) procedure, detailing its application, benefits, and technical execution for the treatment of benign prostatic hyperplasia (BPH). He emphasizes the minimally invasive nature of PUL and its effectiveness in alleviating urinary symptoms while preserving sexual function.

Dr. Herati explains the indications for PUL, stressing the evaluation of prostate size, anatomy, and symptom severity. Ideal candidates typically have lateral lobe enlargement without significant median lobe obstruction.

The procedural technique is outlined with precision, starting with patient preparation and anesthesia. Herati describes the insertion of the cystoscope through the urethra to visualize the prostate and the subsequent deployment of tiny implants to retract the enlarged prostate tissue away from the urethra. Dr. Herati emphasizes the technical aspects critical to the success of the procedure.

The benefits of PUL are highlighted, including its high safety profile, quick recovery, and preservation of erectile and ejaculatory function. Additionally, he discusses complications, which are generally mild and transient. Challenges and limitations of PUL are also addressed.

Read More

Join the GRU Community

- Why Join? -